214 related articles for article (PubMed ID: 20021657)
1. Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
Tan B; Naik H; Jang IJ; Yu KS; Kirsch LE; Shin CS; Craft JC; Fleckenstein L
Malar J; 2009 Dec; 8():304. PubMed ID: 20021657
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
Morris CA; Onyamboko MA; Capparelli E; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright L; Tshefu AK; Meshnick S; Fleckenstein L
Malar J; 2011 May; 10():114. PubMed ID: 21548983
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
4. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
[TBL] [Abstract][Full Text] [Related]
5. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Xing J; Bai KH; Liu T; Wang RL; Zhang LF; Zhang SQ
Xenobiotica; 2011 Mar; 41(3):252-8. PubMed ID: 21175296
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of artesunate in the domestic pig.
Sinou V; Taudon N; Mosnier J; Aglioni C; Bressolle FM; Parzy D
J Antimicrob Chemother; 2008 Sep; 62(3):566-74. PubMed ID: 18559353
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers.
Na-Bangchang K; Krudsood S; Silachamroon U; Molunto P; Tasanor O; Chalermrut K; Tangpukdee N; Matangkasombut O; Kano S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):575-82. PubMed ID: 15689069
[TBL] [Abstract][Full Text] [Related]
8. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.
Morris CA; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
Malar J; 2011 Sep; 10():263. PubMed ID: 21914160
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
Ayyoub A; Methaneethorn J; Ramharter M; Djimde AA; Tekete M; Duparc S; Borghini-Fuhrer I; Shin JS; Fleckenstein L
Antimicrob Agents Chemother; 2015 Dec; 60(3):1450-8. PubMed ID: 26666916
[TBL] [Abstract][Full Text] [Related]
10. Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.
Morris CA; Tan B; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
Antimicrob Agents Chemother; 2013 Dec; 57(12):5889-900. PubMed ID: 24041884
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
Ericsson T; Blank A; von Hagens C; Ashton M; Äbelö A
Eur J Clin Pharmacol; 2014 Dec; 70(12):1453-63. PubMed ID: 25248945
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
Reuter SE; Upton RN; Evans AM; Navaratnam V; Olliaro PL
J Antimicrob Chemother; 2015 Mar; 70(3):868-76. PubMed ID: 25377567
[TBL] [Abstract][Full Text] [Related]
14. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
Karunajeewa HA; Ilett KF; Dufall K; Kemiki A; Bockarie M; Alpers MP; Barrett PH; Vicini P; Davis TM
Antimicrob Agents Chemother; 2004 Aug; 48(8):2966-72. PubMed ID: 15273107
[TBL] [Abstract][Full Text] [Related]
15. An investigation of the auto-induction of and gender-related variability in the pharmacokinetics of dihydroartemisinin in the rat.
Zhu F; Du F; Li X; Xing J
Malar J; 2012 Nov; 11():379. PubMed ID: 23171067
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.
Morris CA; Lopez-Lazaro L; Jung D; Methaneethorn J; Duparc S; Borghini-Fuhrer I; Pokorny R; Shin CS; Fleckenstein L
Am J Trop Med Hyg; 2012 Mar; 86(3):489-495. PubMed ID: 22403324
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC.
Onyamboko MA; Meshnick SR; Fleckenstein L; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright LL; Tshefu AK; Capparelli EV
Malar J; 2011 Feb; 10():49. PubMed ID: 21352601
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
Li Q; Remich S; Miller SR; Ogutu B; Otieno W; Melendez V; Teja-Isavadharm P; Weina PJ; Hickman MR; Smith B; Polhemus M
Malar J; 2014 Jul; 13():281. PubMed ID: 25047305
[TBL] [Abstract][Full Text] [Related]
19. Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration.
Diem Thuy LT; Ngoc Hung L; Danh PT; Na-Bangchang K
Eur J Clin Pharmacol; 2008 Oct; 64(10):993-8. PubMed ID: 18600318
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica.
Keiser J; Gruyer MS; Perrottet N; Zanolari B; Mercier T; Decosterd L
J Antimicrob Chemother; 2009 Mar; 63(3):543-9. PubMed ID: 19168863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
